文献速递糖尿病

SGLT2缺失或抑制对高脂饮食喂养小鼠皮质酮分泌的影响:探索与细胞因子水平的关联

Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.
PubMed 文献 · Diabetologia · 2025-06-20

该研究在高脂饮食喂养小鼠中比较了对照组、长期达格列净治疗组和全身Slc5a2敲除小鼠的代谢与免疫表型。SGLT2缺失小鼠糖耐量和胰岛素敏感性优于对照组和达格列净组,并出现皮质酮分泌的生理性调节,晨间水平低于对照组。全身细胞因子谱显示炎症介质特别是IL-6显著改变,无偏蛋白质组分析显示急性期蛋白下调和谷胱甘肽相关蛋白上调。IL-6处理增加人肾HK2细胞SGLT2表达,提示细胞因子可能参与高血糖效应。

要点

  • SGLT2缺失小鼠糖耐量和胰岛素敏感性优于对照组和达格列净治疗组。
  • SGLT2缺失小鼠晨间皮质酮水平低于对照组,呈现生理性调节。
  • IL-6处理增加人肾HK2细胞SGLT2表达,提示细胞因子与SGLT2表达间可能存在反馈环。

核心结论

  • SGLT2活性、免疫调节与代谢稳态之间可能存在相互作用,且SGLT2表达与细胞因子浓度之间可能存在反馈环。

研究设计与样本

  • 研究比较了高脂饮食喂养的对照小鼠、长期达格列净治疗小鼠和全身Slc5a2敲除小鼠的代谢与免疫表型。

主要发现

  • SGLT2缺失小鼠IPGTT的0-90分钟血糖AUC为1175 ± 57.4 mmol/l × min(平均值 ± 标准误),低于对照组的1857 ± 117.9 mmol/l × min(p=0.05)和达格列净治疗组的1506 ± 68.72 mmol/l × min(p=0.09),且不依赖于尿糖和体重。
  • SGLT2缺失小鼠晨间皮质酮水平低于对照小鼠(p<0.01)。
  • 全身细胞因子谱显示炎症介质显著改变,尤其是IL-6。
  • 无偏蛋白质组分析显示急性期蛋白下调和谷胱甘肽相关蛋白上调。
  • IL-6处理增加人肾HK2细胞中SGLT2表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Despite recent therapeutic advances, achieving optimal glycaemic control remains a challenge in managing type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as effective treatments by promoting urinary glucose excretion. However, the full scope of their mechanisms extends beyond glycaemic control. At present, their immunometabolic effects remain elusive. METHODS: To investigate the effects of SGLT2 inhibition or deletion, we compared the metabolic and immune phenotype between high-fat-diet-fed control mice, mice treated chronically with dapagliflozin, and total-body Slc5a2-knockout mice. RESULTS: SGLT2-null mice exhibited better glucose tolerance and insulin sensitivity (blood glucose during IPGTT AUC 0-90 min 1175 ± 57.4 mmol/l × min, mean ± SEM) compared with control (AUC 0-90 min 1857 ± 117.9 mmol/l × min, p=0.05) or dapagliflozin-treated mice (AUC 0-90 min 1506 ± 68.72 mmol/l × min, p=0.09), independent of glycosuria and body weight. Moreover, SGLT2-null mice demonstrated physiological regulation of corticosterone secretion, with lower morning levels than control mice (p<0.01). Systemic cytokine profiling also unveiled significant alterations in inflammatory mediators, particularly IL-6. Furthermore, unbiased proteomic analysis demonstrated downregulation of acute-phase proteins and upregulation of glutathione-related proteins, suggesting a role in the modulation of antioxidant responses. Conversely, IL-6 treatment increased SGLT2 expression in human kidney HK2 cells, suggesting a role for cytokines in the effects of hyperglycaemia. CONCLUSIONS/INTERPRETATION: Collectively, our data elucidate a potential interplay between SGLT2 activity, immune modulation and metabolic homeostasis, as well as a potential feedback loop between SGLT2 expression and cytokine concentration.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Brisnovali NF, Franco I, Abdelgawwad A, et al. Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels. Diabetologia. 2025. PMID: 40542280. doi:10.1007/s00125-025-06467-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。